title: [Diet therapy in the treatment of neuropediatric disorders].
abstract: OBJECTIVE
  This review focuses on the dietary treatment of four neuropediatric disorders: 1) X-linked adrenoleukodystrophy (X-ALD); 2) attention deficit disorders (ADD); 3) refractory epilepsy; and 4) inborn errors of metabolism.
  
  
  METHODS
  The use of Lorenzo's oil in the treatment of X-ALD has been controversial since no clear efficacy has been demonstrated because of a lack of controlled studies. Although this treatment normalizes the levels of very-long chain fatty acids in children with the cerebral form of X-ALD, the neurological symptoms persist or progress. The dietary treatment of ADD with or without hyperactivity consists of elimination diets such as the Feingold diet and megavitamins. Although the results of several controlled studies are contradictory, there is no scientific evidence that sugar, artificial food colorings or sweeteners are responsible for behavior or learning problems in children. The ketogenic diet has been effective for the control of refractory epilepsy such as infantile spasms and myoclonic seizures. Important side effects include gastrointestinal complaints, metabolic complications, poor growth and nutrition, liver abnormalities and renal calculi. The early identification and treatment of inborn errors of metabolism require prompt diagnosis and correction of metabolic abnormalities. Restriction of protein and fats may be necessary in certain neurometabolic disorders. A variety of special formulas is available to meet the nutritional requirements and avoid offending substances in neurometabolic patients.
  
  
  CONCLUSIONS
  Dietary treatment plays an important role in the management of certain neuropediatric disorders, such as the use of special formulas in inborn errors of metabolism and the ketogenic diet in refractory epilepsy. The efficacy of Lorenzo's oil in the cerebral form of X-ALD and of the elimination of artificial food colorings and sweeteners in ADD remain to be proved.
authors.affiliation: Departamento de Pediatría, Centro Médico de la Universidad de Kansas, Kansas City 66210, USA. echaves17@hotmail.com
authors.forename: E
authors.initials: E
authors.lastname: Chaves-Carballo
mesh_terms: D000326:Adrenoleukodystrophy / Q000503:physiopathology / Q000628:therapy*; D001289:Attention Deficit Disorder with Hyperactivity / Q000503:physiopathology / Q000628:therapy*; D002648:Child; D004032:Diet; D004338:Drug Combinations; D004827:Epilepsy / Q000503:physiopathology / Q000628:therapy*; D004883:Erucic Acids / Q000627:therapeutic use; D006801:Humans; D008661:Metabolism, Inborn Errors / Q000503:physiopathology / Q000628:therapy*; D014304:Triolein / Q000627:therapeutic use
chemical_list: D004338:Drug Combinations; D004883:Erucic Acids; C079420:Lorenzo's oil; D014304:Triolein